Sorrento Therapeutics, Inc. - SRNE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$0
QoQ value delta ($000)
$0
Shares
Total shares
116,056
QoQ shares delta
+587 (+0.51%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SRNE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 5 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
HUNTINGTON NATIONAL BANK 0 5,001 0.0%
Oakworth Capital, Inc. 0 350 0.0%
Financial Gravity Asset Management, Inc. 0 18 0.0%
VSM Wealth Advisory, LLC 0 110,100 0.0%
Financial Gravity Companies, Inc. 0 18 0.0%
First Command Advisory Services, Inc. 0 569 0.0%